MCM
VCYT icon

Moore Capital Management’s Veracyte VCYT Stock Holding History

Moore Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.47M Sell
42,106
-37,654
-47% -$1.58M 0.04% 367
2026
Q1 		$2.57M Buy
79,760
+36,995
+87% +$1.37M 0.05% 244
2025
Q4 		$1.8M Buy
+42,765
New +$1.72M 0.03% 393

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Moore Capital Management's VCYT Position: Q2 2026 in Review

Moore Capital Management reduced its Veracyte (VCYT) stake by 47% in Q2 2026, selling an estimated $1.58M and leaving 42,106 shares worth $2.47M. The position accounts for 0.04% of the portfolio, ranked #367.

Moore Capital Management first reported a position in VCYT in Q4 2025 and has held it in 3 quarters since. The position peaked at $2.57M in Q1 2026. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Moore Capital Management held 42,106 shares of Veracyte worth $2.47M as of Q2 2026.
  • Moore Capital Management sold 37,654 Veracyte shares in Q2 2026, an estimated $1.58M.
  • Veracyte made up 0.04% of Moore Capital Management's portfolio in Q2 2026, its #367 holding.
  • Moore Capital Management first reported a position in Veracyte in Q4 2025 and has held it in 3 quarters since.
  • Moore Capital Management's Veracyte position peaked at $2.57M in Q1 2026.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.